The historical rank and industry rank for Indoco Remedies's OCF Margin % or its related term are showing as below:
NSE:INDOCO'
s OCF Margin % Range Over the Past 10 Years
Min: 5.53 Med: 11.14 Max: 14.02
Current: 12.64
During the past 13 years, the highest OCF Margin % of Indoco Remedies was 14.02%. The lowest was 5.53%. And the median was 11.14%.
NSE:INDOCO's OCF Margin % is ranked better than 59.1% of 956
companies
in the Drug Manufacturers industry
Industry Median: 9.985
vs NSE:INDOCO: 12.64
Indoco Remedies OCF Margin % Related Terms
Indoco Remedies OCF Margin % Historical Data
* Premium members only.
The historical data trend for Indoco Remedies's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indoco Remedies OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Indoco Remedies's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indoco Remedies (NSE:INDOCO) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Indoco Remedies and its competitors. Over the past decade, Indoco Remedies' OCF Margin % has ranged from 5.53 to 14.02. According to the industry distribution chart, Indoco Remedies ranks #391 out of 956 companies in the Drug Manufacturers industry, placing it in the top 40.9%.
Is Indoco Remedies' OCF Margin % too high?
Indoco Remedies' current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 5.53 to a high of 14.02. Based on the distribution chart, Indoco Remedies ranks #391 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Indoco Remedies has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indoco Remedies' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Indoco Remedies ranks #391 out of 956 companies for OCF Margin %. This puts Indoco Remedies in the upper half of its industry. The industry median OCF Margin % is 9.99. Historically, Indoco Remedies' own OCF Margin % has ranged from 5.53 to 14.02 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Indoco Remedies and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indoco Remedies's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indoco Remedies stock overvalued right now?
Based on GuruFocus' analysis, Indoco Remedies (NSE:INDOCO) is currently considered Possible Value Trap. The stock's GF Value™ is ₹358.97, compared to a current price of ₹234.06 — trading 34.8% below its estimated fair value. The current OCF Margin % is 0.00%. Indoco Remedies' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Indoco Remedies (NSE:INDOCO), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indoco Remedies (NSE:INDOCO) Overvalued in 2026?
Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued.
The current stock price of ₹234.06 is trading 34.8% below its estimated GF Value™ of ₹358.97.
GuruFocus considers Indoco Remedies to be Possible Value Trap.
Key valuation signals for NSE:INDOCO:
OCF Margin %: 0.00%
GF Value™: ₹358.97 vs. price of ₹234.06 (34.8% below fair value)
No single metric tells the full story. See the NSE:INDOCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
66GF Score
Get the complete analysis for NSE:INDOCO
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOCO has been successfully added to your 
